Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Keilacker

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Experimental and Clinical Endocrinology|April 1, 1987
5-year follow-up study of C-peptide secretion in newly diagnosed type I diabetics: relations to HLA-phenotype, insulin requirement and metabolic controlI Rjasanowski, D Michaelis, H Keilacker, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|May 1, 1982
Insulin antibodies in juvenile diabetes mellitus. Correlations to diabetic stability, insulin requirement and duration of insulin treatmentH Keilacker, I Rjasanowski, M Ziegler, et al.
Diabetes Research (Edinburgh, Scotland)|January 1, 1994
The detection of autoantibodies to pancreatic islet cells by immunoenzyme histochemistryK D Kohnert, I Rjasanowski, B Hehmke, et al.
Diabetes Care|March 1, 1984
Mumps infection and insulin-dependent diabetes mellitus (IDDM)K P Ratzmann, J Strese, S Witt, et al.
Experimental and Clinical Endocrinology|June 1, 1986
The role of insulin antibodies in insulin treatment of type I diabetesH Keilacker, I Rjasanowski, M Ziegler, et al.
Biomedica Biochimica Acta|January 1, 1986
Kinetic properties of monoclonal insulin antibodiesH Keilacker, H Dietz, S Witt, et al.
Experimental and Clinical Endocrinology|April 1, 1984
Islet cell antibodies in individuals at increased risk for IDDMB Schulz, S Witt, W Hildmann, et al.
Experimental and Clinical Endocrinology|April 1, 1984
Is there a relationship between genetically determined haptoglobin phenotype and insulin-dependent diabetes mellitus (IDDM)?K P Ratzmann, J Strese, H Keilacker, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 1, 1989
Different insulin antibody formation in diabetic patients treated with crystallized or highly purified insulins is a transient phenomenonH Keilacker, I Rjasanowski, K P Woltanski, et al.
International Journal of Clinical & Laboratory Research|January 1, 1996
Antibody response to islet antigens in anti-CD4/prednisolone immune intervention of type 1 diabetesK D Kohnert, B Hehmke, H Keilacker, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Experimental and Clinical Endocrinology|April 1, 1987
5-year follow-up study of C-peptide secretion in newly diagnosed type I diabetics: relations to HLA-phenotype, insulin requirement and metabolic controlI Rjasanowski, D Michaelis, H Keilacker, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|May 1, 1982
Insulin antibodies in juvenile diabetes mellitus. Correlations to diabetic stability, insulin requirement and duration of insulin treatmentH Keilacker, I Rjasanowski, M Ziegler, et al.
Diabetes Research (Edinburgh, Scotland)|January 1, 1994
The detection of autoantibodies to pancreatic islet cells by immunoenzyme histochemistryK D Kohnert, I Rjasanowski, B Hehmke, et al.
Diabetes Care|March 1, 1984
Mumps infection and insulin-dependent diabetes mellitus (IDDM)K P Ratzmann, J Strese, S Witt, et al.
Experimental and Clinical Endocrinology|June 1, 1986
The role of insulin antibodies in insulin treatment of type I diabetesH Keilacker, I Rjasanowski, M Ziegler, et al.
Biomedica Biochimica Acta|January 1, 1986
Kinetic properties of monoclonal insulin antibodiesH Keilacker, H Dietz, S Witt, et al.
Experimental and Clinical Endocrinology|April 1, 1984
Islet cell antibodies in individuals at increased risk for IDDMB Schulz, S Witt, W Hildmann, et al.
Experimental and Clinical Endocrinology|April 1, 1984
Is there a relationship between genetically determined haptoglobin phenotype and insulin-dependent diabetes mellitus (IDDM)?K P Ratzmann, J Strese, H Keilacker, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 1, 1989
Different insulin antibody formation in diabetic patients treated with crystallized or highly purified insulins is a transient phenomenonH Keilacker, I Rjasanowski, K P Woltanski, et al.
International Journal of Clinical & Laboratory Research|January 1, 1996
Antibody response to islet antigens in anti-CD4/prednisolone immune intervention of type 1 diabetesK D Kohnert, B Hehmke, H Keilacker, et al.
Pageof 5